Delivery Order SPE2DR25D1100-SPE2DR26FDB1F
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,289.88 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL, a hormone replacement therapy pharmaceutical. The contract was awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, and utilizes firm fixed-price pricing with no set-aside designation. Performance will be conducted at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,259.36 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,783.91 to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL, with an ultimate completion date of September 16, 2025. This is a firm fixed price contract with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under the company's existing contract vehicle with DLA. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $1,560.00 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on November 28, 2025, with a completion date of December 1, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency has awarded a delivery order valued at $1,554.73 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This competitive award, made on December 9, 2025, represents a firm fixed-price delivery order with an ultimate completion date of December 10, 2025. The contract involves no set-aside designation, indicating the award was made through open competition. AmerisourceBergen Drug Corp will perform this work from its corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $1,619.00 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price, competitively awarded delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. AmerisourceBergen will perform this contract from its corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,133.84 to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on January 20, 2026, with an ultimate completion date of January 21, 2026. This firm fixed-price contract, with no set-aside designation, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a $1,030.88 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed price, non-set-aside contract will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,371.00 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This competitive award, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is a child...
- The Defense Logistics Agency awarded a $1,876.67 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Testosterone Cypionate 200 mg/mL. This competitive, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDB1FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,828.00 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/ml. This competitively awarded, firm fixed-price contract was issued on January 22, 2026, with an ultimate completion date of January 23, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply chain requirements. This delivery order is executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contracting portfolio demonstrates consistent capability in delivering diverse pharmaceutical products across multiple therapeutic domains to military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/21/26 |